TP Zimmerman, V Novokhatny, S Jiang… - US Patent …, 2011 - Google Patents ... Invest., 38(7): 1086-1095 (1959). Ambrus, C, et al., "Insolubilized Activators of the Fibrinolysin Sys- tem," J. Med. 3:270-281 (1972). ... Anlyan, W., et al., "Experiences with Fibrinolysin in Peripheral Vas- cular Occlusive Disease,"^/? J. Cardiol., 6:507-512 (1960). ... Related articles - All 3 versions
A Toren, L Rosenberg… - EP Patent 2,292,257, 2011 - freepatentsonline.com ... 4. The composition according to claim 1, wherein the at least one enzymatic debriding agent comprises enzymes selected from a group consisting of: bromelain, debridase, trypsin, fibrinolysin, fibrinolysin-deoxyribonuclease, Clostridium histolyticum enzyme H-4, collagenase ... Cached
R JI, Q SUN… - Chinese Pharmacological Bulletin, 2011 - en.cnki.com.cn ... Aim To discover the new or novel fibrinolysin from Protobothrops mucrosquamatus venom.The physico-chemical property and biological activity of the interest enzyme were investigated for better understanding of its role in snakebite and evaluating its clinical potential.Methods ... Cached
VJ MARDER - Journal of Thrombosis and Haemostasis, 2011 - Wiley Online Library ... SK), to patients – not for vascular thrombosis, but rather into the pleural space for treatment of fibrinous adhesions, often with strikingly beneficial results [2]. A very active interest also developed for the therapeutic potential of plasmin, at the time called 'fibrinolysin', and by 1957 ...
AI Qureshi - Textbook of Interventional Neurology, 2011 - books.google.com ... procedure. In 1958, Sussmann and Fitch21 from the Division of Neurosurgery at Muhlenberg Hospital in Plainfield, New Jersey reported the results of slow intravenous infusion of fibrinolysin in three patients with hemiplegia. ... Related articles
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
